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now laid the groundwork for clarifying a fundamental binding domains of R2D2. The apparent role of R2D2
mechanistic issue in RNAi: how the double-stranded in siRNA retention after processing provided the first
RNA (dsRNA) silencing trigger makes the transition from indication that R2D2 controls siRNA fate rather than
nuclease substrate to nuclease specificity factor. production, prompting the idea that R2D2 participates
RNAi is a member of a newly discovered set of gene in channeling siRNAs into the RISC complex.
control pathways that all share a common feature: they In previous work with S2 cell extracts, the dsRNA
sequence-specifically silence the expression of genes trigger was added to the live cells before extract prepa-
in response to dsRNA (see Denli and Hannon [2003] for ration (Hammond et al. 2000). However, Liu et al. (2003)
a recent review). The RNAi pathway downregulates gene found that coupled siRNA production and target mRNA
expression at the level of mRNA stability, and the se- cleavage can occur entirely in vitro in S2 cell extracts,
quence specificity of mRNA destruction arises from the and furthermore showed that the siRNA production ma-
sequence of the dsRNA silencing trigger itself. A wide chinery could be crudely but effectively separated from
variety of eukaryotic organisms are capable of mounting RISC complexes by polyethylene glycol (PEG) precipita-
an RNAi response, and often appear to use this pathway tion. These observations set the stage for the critical
to defend against viruses and transposable elements. experiments to test the requirement for the Dicer-2/
In the initiation step of RNAi, Dicer, a member of the R2D2 complex in the effector phase of RNAi. Addition of
ribonuclease III family, processes the dsRNA trigger into Dicer-2 alone to the RISC-containing PEG supernatant
21–23 nucleotide duplex siRNAs (Bernstein et al., 2001). stimulated modest RISC activity in response to a long
Subsequently, the siRNAs are incorporated into the dsRNA trigger, but maximal stimulation was only ob-
RNA-induced silencing complex (RISC), where they guide served upon addition of the Dicer-2/R2D2 complex. Mu-
tation of R2D2’s dsRNA binding domains abolished thethe site-specific cleavage of complementary mRNA (Ham-
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stimulation of RISC activity. Importantly, similar effects
were observed when pre-cleaved siRNAs were used to
trigger RISC, indicating that RISC does not efficiently
utilize siRNAs in the absence of R2D2. Finally, the au-
thors drove this last point home by showing that the
known RISC component Argonaute2 (Hammond et al.,
2001) is not efficiently coselected with biotinylated
siRNAs unless functional Dicer-2/R2D2 complex is pres-
ent. The clear implication is that R2D2 helps to mediate
the transition between the initiation and execution
phases of RNAi.
Naturally, the identification of R2D2 (and its role in
bridging the two main stages of RNAi) raises a new set
of questions. Exactly how does R2D2 funnel siRNAs
from Dicer-2 to RISC? Is this an active, energy-requiring
process? Does R2D2 accompany siRNAs into RISC, or
does it simply hand them off? siRNAs with non-native
structures (e.g., with 5-hydroxyl termini) have been
shown to be excluded from RISC, implying that certain
structural features such as 5-phosphates may license
bona fide siRNAs for RNAi (Nyka¨nen et al., 2001). Now
that R2D2 has been shown to be intimately involved in
loading siRNAs into RISC, does R2D2 help to discrimi-
nate against siRNA impostors? The results of Liu et al.
(2003), combined with the experimental tools that now
exist (e.g., anti-R2D2 antibodies, recombinant R2D2
protein, and r2d2 mutant flies), foreshadow rapid prog-
ress in answering these and other fundamental mecha-
nistic questions about the RNAi pathway.
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